期刊文献+

宫颈癌细胞摄取^(99)Tc^mN(NOEt)_2与^(99)Tc^m-MIBI动力学对比研究 被引量:9

Comparative study of uptake and washout of ^( 99)Tc^mN(NOEt)_2 with ^( 99)Tc^m-MIBI in human cervical carcinoma cell line Hela
暂未订购
导出
摘要 目的 研究99Tcm 氮 二 (N 乙基 N 乙氧基二硫代氨基甲酸盐 ) [N(NOEt) 2 ]在人宫颈癌Hela细胞中的摄取动力学。方法 用放射性核素示踪法研究人宫颈癌Hela细胞在 37℃和 2 2℃时对99TcmN(NOEt) 2 和99Tcm 甲氧基异丁基异腈 (MIBI)的摄取动力学。结果 Hela细胞摄取99TcmN(NOEt) 2的峰值为 4 6 .15 % ,99Tcm MIBI为 12 .6 0 % (P <0 .0 1) ;5min时Hela细胞摄取99TcmN(NOEt) 2 为峰值的6 5 % ,99Tcm MIBI为 5 0 % (P <0 .0 5 ) ;6 0min时99TcmN(NOEt) 2 在Hela细胞中的滞留率为 6 6 0 2 % ,99Tcm MIBI为 5 6 .6 7% (P <0 .0 5 ) ;Hela细胞对99TcmN(NOEt) 2 的摄取不依赖温度 ,99Tcm MIBI摄取则呈温度依赖性。结论 99TcmN(NOEt) 2 可能较99Tcm MIBI更适用于肿瘤显像 ,有潜在的临床应用价值。 ObjectiveTo investigate the cellular kinetics of 99Tcm-bis(N-ethoxy-N-ethyl dithiocarbamato)-nitrido N(NOEt) 2 in human cervical carcinoma Hela cells and to compare it with the cellular kinetics of 99Tcm-methoxyisobutylisonitrile (MIBI) in similar conditions; to define the possible clinical value of 99TcmN(NOEt) 2 in tumor imaging. MethodsAccording to the principle of radionuclide tracer technique, 99TcmN(NOEt) 2 or 99Tcm-MIBI were incubated with Hela cells at 37 ℃ or at 22 ℃, at several time points after incubation, the uptake and washout characteristics of radiotracers in Hela cells were investigated and compared. ResultsThe maximum uptake of 99TcmN(NOEt) 2 in Hela cells was 46.15%, that of 99Tcm-MIBI was 12.60%(P<0.01). The uptake of 99TcmN(NOEt) 2 after 5 min incubation in Hela cells was 65% of total uptake, uptake of 99Tcm-MIBI was 50% of total uptake( P<0.05); 1 h after removal of the unbound tracer, 66.02% of the total uptake of 99TcmN(NOEt) 2 was retained in the Hela cells, 56.67% of 99Tcm-MIBI was retained (P<0.05); not like 99Tcm-MIBI, the cellular kinetics of 99TcmN(NOEt) 2 was not temperature-dependent (the cellular kinetics was similar at 37 ℃ and at 22 ℃, P>0.05). ConclusionIn vitro data suggest that 99TcmN(NOEt) 2 may be a tracer better than 99Tcm-MIBI for tumor imaging; 99TcmN(NOEt) 2 has potential application in clinical use.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2002年第6期363-365,共3页 Chinese Journal of Nuclear Medicine
关键词 宫颈癌 Hela细胞 N(NOET)2 MIBI 药代动力学 放射性核素示踪法 肿瘤显像 Uterine neoplasms Hela cells N(NOEt) 2 MIBI Pharmacokinetics
  • 相关文献

参考文献8

  • 1Pasqualini R, Duatti A, Bellancle E, et al. Bis(dithiocarbamato)nitrodo 99Tcm radiopharmaceuticals: a class of neutral myocardial imaging agents. J Nucl Med, 1994, 35: 334-341.
  • 2方平,周翔,吴春英,罗世能,陈正平,纪书仁.中性心肌显像剂^(99m)TcN(NOEt)_2的制备及生物分布[J].中华核医学杂志,1997,17(1):20-22. 被引量:10
  • 3De Beco V, Moretti JL, Duran Cordobes M, et al. Uptake of 99TcmN-NOEt in cancer lines sensitive(se) and resistant(rt) to chemotherapy: comparison with 99Tcm-sestamibi (Abstract). J Nucl Med, 1996, 37: 189-190P.
  • 4Vanzetto G, Fagret D, Pasqualini R, et al. Biodistribution, dosimetry, and safety of myocardial perfusion imaging agent 99TcmN-NOEt in healthy volunteers. J Nucl Med, 2000, 41: 141-148.
  • 5Stalteri MA, Parrott SJ, Griffiths VA, et al. Uptake of 99Tcm-nitrido dithiocarbomate complexes by tumor cells. Nucl Med Commun, 1997, 18: 870-877.
  • 6Arbab AS, Koizumi K, Toyama K, et al. Uptake of 99Tcm-tetrofosmin, 99Tcm-MIBI and 201Tl in tumor cell lines. J Nucl Med, 1996, 37: 1551-1556.
  • 7De Jong M, Bemard BF, Breeman WAP, et al. Comparison of uptake of 99Tcm-MIBI, 99Tcm-tetrofosmin and 99Tcm-Q12 into human breast cancer cell lines. Eur J Nucl Med, 1996, 23: 1361-1366.
  • 8Crankshaw C, Piwnica-Worms D. 99Tcm-sestamibi may be a transport substrate of the human multidrug resistance-associated protein (MRP) (Abstract). J Nucl Med, 1996,37 Suppl:247.

共引文献9

同被引文献77

引证文献9

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部